OPL Stock Overview
Opyl Limited develops digital tools that enhance healthcare experience for patients in Australia.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Opyl Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.022 |
| 52 Week High | AU$0.062 |
| 52 Week Low | AU$0.021 |
| Beta | 2.13 |
| 1 Month Change | -15.38% |
| 3 Month Change | -21.43% |
| 1 Year Change | -64.52% |
| 3 Year Change | -78.00% |
| 5 Year Change | -95.60% |
| Change since IPO | -99.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| OPL | AU Software | AU Market | |
|---|---|---|---|
| 7D | 4.8% | 3.6% | -1.8% |
| 1Y | -64.5% | 27.3% | -1.9% |
Return vs Industry: OPL underperformed the Australian Software industry which returned 27.3% over the past year.
Return vs Market: OPL underperformed the Australian Market which returned -1.9% over the past year.
Price Volatility
| OPL volatility | |
|---|---|
| OPL Average Weekly Movement | n/a |
| Software Industry Average Movement | 9.2% |
| Market Average Movement | 8.5% |
| 10% most volatile stocks in AU Market | 15.5% |
| 10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: Insufficient data to determine OPL's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine OPL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | n/a | Michelle Gallaher | https://www.opyl.ai |
Opyl Limited develops digital tools that enhance healthcare experience for patients in Australia. The company also delivers deep market insights from social media data and enhance clinical research process. It offers Opin, a clinical trial recruitment platform that leverages social media, search engine optimization technologies and emerging artificial intelligence science, and matching patients directly to clinical trials; and social media marketing agency services, such as client and account management services for pharmaceutical, medtech, and biotech industries.
Opyl Limited Fundamentals Summary
| OPL fundamental statistics | |
|---|---|
| Market Cap | AU$1.76m |
| Earnings (TTM) | -AU$1.24m |
| Revenue (TTM) | AU$901.42k |
2.0x
P/S Ratio-1.4x
P/E RatioIs OPL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OPL income statement (TTM) | |
|---|---|
| Revenue | AU$901.42k |
| Cost of Revenue | AU$1.57m |
| Gross Profit | -AU$669.78k |
| Other Expenses | AU$570.53k |
| Earnings | -AU$1.24m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.016 |
| Gross Margin | -74.30% |
| Net Profit Margin | -137.60% |
| Debt/Equity Ratio | 0% |
How did OPL perform over the long term?
See historical performance and comparison